23 research outputs found
RNA-Seq gene expression profiling of HepG2 cells: the influence of experimental factors and comparison with liver tissue
Defining Early-Onset Colon and Rectal Cancers
Background: Colorectal cancer (CRC) incidence is rising in the young, yet the age of those affected is not clearly defined. In this study, we identify such cohorts and define clinicopathological features of early-onset colon and rectal cancers.Methods: The Surveillance, Epidemiology and End Results Program (SEER) database was queried to compare clinicopathological characteristics of colon and rectal cancers diagnosed during 1973–1995 with those diagnosed during 1995–2014.Results: We identified 430,886 patients with colon and rectal cancers. From 1973–1995 to 1995–2014, colon cancer incidence increased in patients aged 20–44 years, while rectal cancer incidence increased in patients aged ≤54 years. The percent change of cancer incidence was greatest for rectal cancer with a 41.5% (95% confidence interval (CI): 37.4–45.8%) increase compared to a 9.8% (CI: 6.2–13.6%) increase in colon cancer. Colon cancer has increased in tumors located in ascending, sigmoid, and rectosigmoid locations. Adenocarcinoma histology has increased in both colon and rectal cancers (P < 0.01), but mucinous and signet ring cell subtypes have not increased (P = 0.13 and 0.08, respectively). Incidence increases were race-specific, with rectal cancer seeing similar rises in white (38.4%, CI: 33.8–43.1%) and black populations (38.0%, CI: 26.2–51.2%), while colon cancer as a whole saw a rise in white (11.5%, CI: 7.2–15.9%) but not black populations (−6.8%, CI: −14.6–1.9%).Conclusions: Our study underscores the existence of key differences between early-onset colon (20–44 years) and rectal cancers (≤54 years) and provides evidence-based inclusion criteria for future investigations. We recommend that future research of CRC in the young should avoid investigating these cases as a single entity
A rare case of splenic pseudoaneurysm in pediatric splenic blunt trauma patient: Review of diagnosis and management
Introduction: Splenic pseudoaneurysms (SPA) are a rare but serious sequela of blunt traumatic injury to the spleen. Management of adult blunt splenic trauma is well-studied, however, in children, the management is much less well-defined.
Presentation of case: A 15 year-old male presented with severe abdominal pain of acute onset after sustaining injury to his left side while playing football. FAST was positive for free fluid in the abdomen. Initial abdomen CT demonstrated a grade III/IV left splenic laceration with moderate to large hemoperitoneum with no active extravasation or injury to the splenic vessels noted. A follow-up CT angiography of the abdomen demonstrated a splenic hypervascular structure suspicious for a small pseudoaneurysm. Splenic arteriogram which demonstrated multiple pseudoaneurysms arising from the second order splenic artery branches which was angioembolized and treated.
Discussion & conclusion: Questions still remain regarding the timing of repeat imaging for diagnosis of SPA following non-operative blunt splenic trauma, which patients should be imaged, and how to manage SPA upon diagnosis. More clinical study and basic science research is warranted to study the disease process of SPA in pediatric patient. We believe that our proposed management algorithm timely detect formation of delayed SPA formation and addresses the possible fatal disease course of pediatric SPA
On calculation of dynamic regimes of a vibration activator of fine powders
International audienceA model of a single ball motion in a vertically vibrating cylinder is proposed. The model is non-linear and takes into account impacts of the ball at the top and bottom end of the cylinder. The intensity of energy exchange at these impacts was calculated as a function of process parameters: the cylinder height, the amplitude and frequency of its vibration, and some others. It was shown the intensity is very sensitive to these parameters combination what has to be taken into account in vibration activators design and choosing their operating regimes
Gene Alterations of N6-Methyladenosine (m6A) Regulators in Colorectal Cancer: A TCGA Database Study
N6-methyladenosine (m6A) plays an important role in many cancers. However, few studies have examined the role of m6A in colorectal CRC. To examine the effect of m6A on CRC, we studied the genome of 591 CRC cases from The Cancer Genome Atlas (TCGA). The relationship between the messenger RNA (mRNA) expression, copy number variation (CNVs), and mutations of m6A “Writers,” “Readers,” and “Erasers,” prognosis, immune cell infiltration, and genetic mutations in CRC cases were analyzed. CNVs and mutations were found in thirteen m6A regulators. As expected, gain and amplification of m6A regulators increased the mRNA expression of these regulators, while deletion led to reduction in the mRNA expression. Moreover, CNVs and mutation of these regulators were significantly associated with APC, TP53, and microsatellite instability (MSI) status (p<0.001, p<0.001, and p=0.029, respectively). CNVs of m6A regulators also correlated with inferred immune cell infiltration in CRC tissues, especially in colon tissues. Additionally, alterations of RBM15, YTHDF2, YTHDC1, YTHDC2, and METTL14 genes were related to the worse overall survival and disease-free survival (DFS) of CRC patients. Specifically, the deletion status of “Writers” was also correlated to the DFS of CRC patients (p=0.02). Gene set enrichment analysis found that FTO was involved in mRNA 3′ end processing, polyubiquitin binding, and RNA polymerase promoter elongation, while YTHDC1 was related to interferon-alpha and gamma response. In conclusion, a novel relationship was identified between CNVs and mutations of m6A regulators with prognosis and inferred immune function of CRC. These findings will improve the understanding of the relationship of m6A in CRC
Topical intraperitoneal papaverine to minimize non-viable bowel resection from non-occlusive bowel ischemia in neonatal segmental volvulus: A case report
AbstractArrest in the embryologic intestinal rotation around the superior mesenteric artery prevents proper mesenteric attachment and subjects the gut to volvulus and ischemia which may lead to bowel resection. The length of non-viable resected bowel has been shown by Teitelbaum et al. to be an independent predictor of survival in patients with postoperative short bowel syndrome (RR = 5.74, P = .003). Non-occlusive mesenteric ischemia (NOMI) is a feed-forward loop of vasoconstriction that aggravates the primary ischemic injury. It is an initially reversible process and a potential point of intervention for preservation of viable bowel. The Boley et al. algorithm for management of adult NOMI utilizes intravascular papaverine infusion to increase intracellular cAMP, decreasing calcium concentration and halting vasospasm. We present a modified version of this approach using topical papaverine in the setting of neonatal post-ischemic NOMI, with the goal of minimizing bowel resection
Detection of Marker miRNAs, Associated with Prostate Cancer, in Plasma Using SOI-NW Biosensor in Direct and Inversion Modes
Privacy Concerns About Personal Health Information and Fear of Unintended Use of Biospecimens Impact Donations by African American Patients
Chromosome 18 Transcriptome Profiling and Targeted Proteome Mapping in Depleted Plasma, Liver Tissue and HepG2 Cells
The final goal of the Russian part of the Chromosome-centric
Human
Proteome Project (C-HPP) was established as the analysis of the chromosome
18 (Chr 18) protein complement in plasma, liver tissue and HepG2 cells
with the sensitivity of 10<sup>–18</sup> M. Using SRM, we have
recently targeted 277 Chr 18 proteins in plasma, liver, and HepG2
cells. On the basis of the results of the survey, the SRM assays were
drafted for 250 proteins: 41 proteins were found only in the liver
tissue, 82 proteins were specifically detected in depleted plasma,
and 127 proteins were mapped in both samples. The targeted analysis
of HepG2 cells was carried out for 49 proteins; 41 of them were successfully
registered using ordinary SRM and 5 additional proteins were registered
using a combination of irreversible binding of proteins on CN-Br Sepharose
4B with SRM. Transcriptome profiling of HepG2 cells performed by RNAseq
and RT-PCR has shown a significant correlation (<i>r</i> = 0.78) for 42 gene transcripts. A pilot affinity-based interactome
analysis was performed for cytochrome b5 using analytical and preparative
optical biosensor fishing followed by MS analysis of the fished proteins.
All of the data on the proteome complement of the Chr 18 have been
integrated into our gene-centric knowledgebase (www.kb18.ru)
Chromosome 18 Transcriptome Profiling and Targeted Proteome Mapping in Depleted Plasma, Liver Tissue and HepG2 Cells
The final goal of the Russian part of the Chromosome-centric
Human
Proteome Project (C-HPP) was established as the analysis of the chromosome
18 (Chr 18) protein complement in plasma, liver tissue and HepG2 cells
with the sensitivity of 10<sup>–18</sup> M. Using SRM, we have
recently targeted 277 Chr 18 proteins in plasma, liver, and HepG2
cells. On the basis of the results of the survey, the SRM assays were
drafted for 250 proteins: 41 proteins were found only in the liver
tissue, 82 proteins were specifically detected in depleted plasma,
and 127 proteins were mapped in both samples. The targeted analysis
of HepG2 cells was carried out for 49 proteins; 41 of them were successfully
registered using ordinary SRM and 5 additional proteins were registered
using a combination of irreversible binding of proteins on CN-Br Sepharose
4B with SRM. Transcriptome profiling of HepG2 cells performed by RNAseq
and RT-PCR has shown a significant correlation (<i>r</i> = 0.78) for 42 gene transcripts. A pilot affinity-based interactome
analysis was performed for cytochrome b5 using analytical and preparative
optical biosensor fishing followed by MS analysis of the fished proteins.
All of the data on the proteome complement of the Chr 18 have been
integrated into our gene-centric knowledgebase (www.kb18.ru)